Marker Therapeutics, Inc.

MRKR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 19, 2026 FORM 8-K
10-Q Aug 14, 2026 10-Q
10-Q May 15, 2026 10-Q
8-K May 4, 2026 FORM 8-K
DEFA14A Mar 20, 2026 DEFA14A
ARS Mar 20, 2026 ARS
DEF 14A Mar 20, 2026 FORM DEF 14A
8-K Mar 19, 2026 FORM 8-K
10-K Mar 18, 2026 10-K
PRE 14A Mar 10, 2026 FORM PRE 14A
8-K Feb 9, 2026 FORM 8-K
4 Nov 19, 2025 PRIMARY DOCUMENT
4 Nov 19, 2025 PRIMARY DOCUMENT
4 Nov 19, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Nov 17, 2025
SCHEDULE 13G/A Nov 14, 2025
8-K Nov 14, 2025 FORM 8-K
10-Q Nov 13, 2025 10-Q
8-K Nov 5, 2025 FORM 8-K
4 Nov 4, 2025 PRIMARY DOCUMENT
4 Nov 4, 2025 PRIMARY DOCUMENT
3 Nov 4, 2025 PRIMARY DOCUMENT
8-K Oct 6, 2025 FORM 8-K
8-K Aug 26, 2025 FORM 8-K
SCHEDULE 13D/A Aug 20, 2025
← Newer Page 1 of 36 · 896 filings Older →